{"title":"JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma | Science","link":"https://www.science.org/doi/10.1126/science.ade8520","date":1718974860000,"content":"Unleashing antitumor T cell activity by checkpoint inhibitor immunotherapy is effective in cancer patients, but clinical responses are limited. Cytokine signaling through the Janus kinase (JAK)â€“signal transducer and activator of transcription (STAT) ...","author":"","siteTitle":"Science","siteHash":"08244134beaa7712a45a99601e5e0d25fd23f6384c4a65e503ee732006dc374e","entryHash":"ee616fdc953d2dd3af5f9dbdfa02ed6c6800004663f6fdd2d091603291dd4422","category":"Interdisciplinary"}